Convatec Group Plc (CTEC) is a leading medical instruments & supplies business based in the UK. It opened the day at 209.2p after a previous close of 207.6p. During the day the price has varied from a low of 204.6p to a high of 210p. The latest price was 205.4p (25 minute delay). Convatec Group is listed on the London Stock Exchange (LSE) and employs 9,197 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Convatec Group's share price has had significant negative movement.
Its last market close was 183.8p, which is 14.83% down on its pre-crash value of 215.8p and 29.07% up on the lowest point reached during the March crash when the shares fell as low as 142.4p.
If you had bought £1,000 worth of Convatec Group shares at the start of February 2020, those shares would have been worth £829.42 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £881.96.
|52-week range||138.9814p - 223.2632p|
|50-day moving average||204.36p|
|200-day moving average||195.0238p|
|Wall St. target price||2.21p|
|Dividend yield||0.04p (2.18%)|
|Earnings per share (TTM)||1.2p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-14)||1.88%|
|1 month (2020-12-22)||1.38%|
|3 months (2020-10-22)||11.63%|
|6 months (2020-07-22)||0.88%|
|1 year (2020-01-22)||-1.49%|
|2 years (2019-01-21)||45.11%|
|3 years (2018-01-19)||9.84%|
Valuing Convatec Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Convatec Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Convatec Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 169x. In other words, Convatec Group shares trade at around 169x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Convatec Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1621. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Convatec Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Convatec Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £409.7 million.
The EBITDA is a measure of a Convatec Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£1.8 billion|
|Operating margin TTM||12.93%|
|Gross profit TTM||£955.6 million|
|Return on assets TTM||4.09%|
|Return on equity TTM||1.56%|
|Market capitalisation||£4.1 billion|
TTM: trailing 12 months
Dividend payout ratio: 4400.5% of net profits
Recently Convatec Group has paid out, on average, around 4400.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.18% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Convatec Group shareholders could enjoy a 2.18% return on their shares, in the form of dividend payments. In Convatec Group's case, that would currently equate to about 0.04p per share.
Convatec Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 3 September 2020 (the "ex-dividend date").
Over the last 12 months, Convatec Group's shares have ranged in value from as little as 138.9814p up to 223.2632p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Convatec Group's is 0.7736. This would suggest that Convatec Group's shares are less volatile than average (for this exchange).
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.